Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-06EMA Authorised: Docetaxel Kabi (docetaxel) — Fresenius Kabi Deutschland GmbH
EU authorization of Docetaxel Kabi (docetaxel) for multiple cancer indications including head and neck neoplasms, non-small cell lung carcin…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Use of Tracking Devices to Locate Abnormalities During Invasive Procedures [NA]
NIH-sponsored clinical trial update describes a study evaluating tracking devices to locate abnormalities during invasive procedures, with e…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies
The document provides an update to the follow-up protocol for subjects previously enrolled in NCI Surgery Branch studies. It covers follow-u…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: DESTINY-PANTUMOUR04
Clinical trial update for the DESTINY-PANTUMOUR04 study sponsored by AstraZeneca, evaluating trastuzumab deruxtecan across multiple cancer t…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Evaluation of the Efficacy of Negative Pressure Wound Therapy on Perineal Healing Following Abdominoperineal Amputation [NA]
A clinical trial is evaluating negative pressure wound therapy for perineal healing after abdominoperineal amputation in adenocarcinoma pati…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating a T cell receptor–based immunotherapy for patients with metastatic non-small cell lung cancer is current…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic Cancer [EARLY_Phase 1]
An early-phase clinical trial is evaluating the PET imaging agent 18F-Clofarabine to measure deoxycytidine kinase activity in patients with …
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
Stanford University is conducting a clinical trial evaluating novel serum markers to monitor response to anti-cancer therapy. The study is c…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies [Phase 1]
A Phase 1 clinical trial update evaluating the safety of a quadruple chemotherapy combination (irinotecan with 5-FU/leucovorin, oxaliplatin,…
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma. [Phase 1]
Phase 1 study of BA3182 in patients with adenocarcinoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: EchoTip AcuCore Post-Market Clinical Study
Completed post-market clinical study update for the EchoTip AcuCore device, detailing the completion of the post-market evaluation.
-
EMA approval · 2025-08-04EMA Authorised: Docetaxel Kabi (docetaxel) — Fresenius Kabi Deutschland GmbH
The EMA authorised Docetaxel Kabi (docetaxel) from Fresenius Kabi Deutschland GmbH for multiple cancer indications, including head and neck …
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Jump: MR Simulation For Radiation Therapy Master Protocol [NA]
Clinical trial update for the Jump: MR Simulation For Radiation Therapy Master Protocol, sponsored by Brigham and Women's Hospital, currentl…
-
CLINICAL_TRIALS trial_result · 2025-06-19Clinical Trial Update: Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study [Phase 2]
Phase 2 CABATEN trial evaluated cabozantinib in combination with atezolizumab for advanced neuroendocrine neoplasms of the endocrine system.…
-
CLINICAL_TRIALS withdrawal · 2025-05-18Clinical Trial Update: Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease [Phase 2]
A Phase 2 trial evaluating high-dose intravenous ascorbic acid in measurable solid tumors has been withdrawn, sponsored by Situs Cancer Rese…
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: PRIMER: Development of Daily Online Magnetic Resonance Imaging for Magnetic Resonance Image Guided Radiotherapy
This clinical trial registration outlines the PRIMER study to develop daily online MRI for MRI-guided radiotherapy in patients with adenocar…
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial is evaluating amplitude-modulated radiofrequency electromagnetic fields for metastatic pancreatic cancer, and the s…
-
EMA approval · 2025-02-13EMA Authorised: Docetaxel Accord (docetaxel) — Accord Healthcare S.L.U.
The EMA authorised Docetaxel Accord (docetaxel) from Accord Healthcare for multiple cancer indications, including head and neck cancer, non-…
-
CLINICAL_TRIALS research · 2024-10-17Clinical Trial Update: Beyond TME Origins [NA]
Imperial College London reports a recruiting cancer trial related to adenocarcinoma; no specific drug names are provided in the snippet.
-
EMA approval · 2024-07-31EMA Authorised: Taxotere (docetaxel) — Sanofi Winthrop Industrie
The EMA authorised Taxotere (docetaxel) for multiple cancer indications including head and neck cancer, non-small cell lung cancer, gastric …
-
CLINICAL_TRIALS research · 2024-05-21Clinical Trial Update: A Cancer Vaccine (Labvax 3(22)-23) and GM-CSF Alone or in Combination With Pembrolizumab for the Treatment of Advanced Stage Adenocarcinoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Labvax 3(22)-23 with GM-CSF, alone or in combination with pembrolizumab, in patients with advanced ade…
-
CLINICAL_TRIALS withdrawal · 2022-12-05Clinical Trial Update: Methadone for 'Adenocarcinopathic' Pain Treatment [Phase 3]
Phase 3 trial of methadone for cancer-related pain was withdrawn.
-
CLINICAL_TRIALS trial_result · 2022-11-01Clinical Trial Update: A Study of GSK2256098 and Trametinib in Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial update of GSK2256098 with trametinib in advanced pancreatic cancer has completed.
-
EMA withdrawal · 2022-05-20EMA Withdrawn: Docetaxel Zentiva (previously Docetaxel Winthrop) (docetaxel) — Zentiva k.s.
The EMA has withdrawn Docetaxel Zentiva (docetaxel) from the market. The therapeutic areas formerly associated include head and neck neoplas…
-
EMA withdrawal · 2021-12-14EMA Withdrawn: Docetaxel Teva (docetaxel) — Teva B.V.
The EMA has withdrawn Docetaxel Teva, an injectable chemotherapy containing docetaxel, from the European market.